Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 644Observational 6Expanded_access 2

Sponsor

Cancer Type

Plasma cell 3Classical hematology 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Multiple Myeloma 3Immunologic Deficiency Syndromes 2Thalassemia 1Neoplasms 1Myelodysplastic Syndromes 1Muscle Neoplasms 1Metabolic Diseases 1Melanoma 1Lymphoma 1Hemoglobinopathies 1Hematologic Neoplasms 1Fanconi Anemia 1Chronic Pain 1Breast Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × Melphalan × Clear all
NCT03016806 2025-10-10

Umbilical Cord Blood Transplantation From Unrelated Donors

University of Rochester

Recruiting
30 enrolled
Classical hematologyLymphoidMyeloidPlasma cell

Anemia, Aplastic, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Multiple Myeloma, Myelodysplastic Syndromes

NCT06245629 2024-11-29

Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Uppsala University

Recruiting
100 enrolled
Plasma cell

Multiple Myeloma

NCT06154590 2023-12-04

NASBP-B-09

Paradyne Networks A Foundation

Not yet recruiting
100 enrolled
Breast

Breast Neoplasms, Neoplasms, Muscle Neoplasms, Chronic Pain

NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT01920516 2019-02-27

ILI

International Group of Endovascular Oncology

Unknown
40 enrolled
Dermatologic

Melanoma

NCT02474563 2015-06-30

Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma

Janssen Korea, Ltd., Korea

Completed
171 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡